Human Microbiome Therapeutics
Microbiome studies help explore treatments for genetic disorders
How buildings influence the microbiome and human health
Study finds microbiome changes dynamically and favors important host-relevant functions
Natural compounds in gut microbiome show promise for inflammation treatment
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer
Microbiome
Microbiome studies help explore treatments for genetic disorders
Study finds microbiome changes dynamically and favors important host-relevant functions
Engineers develop innovative microbiome analysis software tools
Exploring the Microbiome Reveals Novel Treatments for Genetic Disorders
Trio of scientists to unlock mystery, power of microbiome
The Paternal Gut Microbiome Can Affect Offspring Health
The Long, Controversial Search for a 'Cancer Microbiome'
Father's gut microbiome may affect infant health
How buildings influence the microbiome and human health
Why a balanced scalp microbiome is key to getting healthy, thick hair
Human Microbiome
Microbiome studies help explore treatments for genetic disorders
How buildings influence the microbiome and human health
Study finds microbiome changes dynamically and favors important host-relevant functions
The Human Microbiome and Aging: What’s the Latest Research?
Human Microbiome Project
Nutrition and Health: Human Microbiome
Understanding the microbiome as an ‘overlooked critical organ’
Natural compounds in gut microbiome show promise for inflammation treatment
The microbiome changes dynamically and favours important host-relevant functions
Microbiome Therapeutics
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Startup launched by 3 UC scientists, including husband of Nobel laureate Jennifer Doudna, hires CEO
Fecal Transplant Shows Promise for Easing Inflammatory Bowel Disease Symptoms
Microbiota Therapeutics Could Become Strong Ally in IBD Treatment
Seed Health Appoints Microbiome Pioneer Zain Kassam, M.D., M.P.H., as Chief Medical Officer
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT